Articles of the Month
Videos
Articles
Different inflammatory features of asthma according to gut microbiome enterotype
Sohn, K.-H., Choi, S., Jung, J.-W., et al. Allergy. First published: 18 May 2023
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric observational phase 4 real-life study (DUPIREAL)
De Corso, E., Pasquini, E., Trimarchi, M., et al. Allergy. First published: 18 May 2023
Bulk T-Cell Receptor Sequencing Confirms Clonality in Pediatric EoE and Identifies a Food-Specific Repertoire
Janarthanam, R., Kuang, F.L., Zalewski, A., et al. Allergy. First published: 18 May 2023
Sinus inflammation and chronic rhinosinusitis are associated with a diagnosis of new onset asthma in the following year
Schwartz, BS, Pollak, JS, Bandeen-Roche, K, et al. Allergy. First published: 17 May 2023
Allergy to stings and bites from rare or locally important arthropods: worldwide distribution, available diagnostics, and treatment
Sturm, G.J., Boni, E., Antolín-Amérigo, D., et al. Allergy. First published: 16 May 2023
Stepping off the beaten path: A multiomic atlas uncovers novel trajectories of T-cell exhaustion
Falduto, G.H. and Schwartz, D.M. Allergy. First published: 16 May 2023
Glucocorticoids are differentially synthesized along the murine and human respiratory tree
Merk, VM, Renzulli, P, Vrugt, B, et al. Allergy. First published: 12 May 2023
Adventitial stromal cells and myofibroblasts recruit pro- and anti-inflammatory immune cells in allergic airway inflammation
Xu, E., Cao, G., Yang, Z., et al. Allergy. First published: 12 May 2023
Laundry detergents and surfactants induced eosinophilic airway inflammation by increasing IL-33 expression and activating ILC2s
Saito, K., Orimo, K., Kubo, T., et al. Allergy. First published: 10 May 2023
Direct cleavage and activation of gasdermin B by allergens
Panganiban, R.A., Mwase, C., Park, J.-A. and Lu, Q. Allergy. First published: 10 May 2023
Oral prednisone regulates human skin T cells in delayed-type hypersensitivity reaction elicited by diphencyprone
Mehta, H., Jack, C., Maari, C., et al. Allergy. First published: 10 May 2023
Mapping the way to strengthening epithelial barriers: Neuronal circuits in mucus regulation
López-Sanz, C., Jiménez-Saiz, R. and Nuñez-Borque, E. Allergy. First published: 07 May 2023
The future of food allergy: Challenging existing paradigms of clinical practice
Anagnostou, A, Lieberman, J, Greenhawt, M, et al. Allergy. First published: 02 May 2023
Arsenic exposure and pruritus: Evidence from observational, interventional, and mendelian randomization studies
Huang, X, Xiao, Y, Jing, D, et al. Allergy. First published: 02 May 2023
25-hydroxyvitamin D and risk of atopic diseases and infections in early childhood
Brustad, N., Kim, M., Skov, F., et al. Allergy. First published: 02 May 2023
The One Health approach for allergic diseases and asthma
Jutel, M, Mosnaim, GS, Bernstein, JA, et al. Allergy. First published: 29 April 2023
Anti-PD1 therapy outcome can be predicted by pre-therapy IFN-I responsiveness of Teff cells
Grandits, M., Chauhan, J. and Bax, H.J. Allergy. First published: 29 April 2023
Eosinophils from A to Z
Gigon, L, Fettrelet, T, Yousefi, S, Simon, D, Simon, H-U. Allergy. First published: 27 April 2023
The changing global prevalence of asthma and atopic dermatitis
Denton, E., O’Hehir, R.E. and Hew, M. Allergy. First published: 27 April 2023
A multicenter time series study on pollen exposure and COVID-19 infection in five cities in China
Yang, X., Zhang, J., Sima, Y., Zhao, J., Wang, X. and Zhang, L. Allergy. First published: 26 April 2023
An update on recent developments and highlights in food allergy
Locke, A., Hung, L., Upton, J.E.M., O’Mahony, L., Hoang, J. and Eiwegger, T. Allergy. First published: 23 April 2023
The Step-Down approach in children with Cow's Milk Allergy: results of a randomized controlled trial
Nocerino, R., Coppola, S., Carucci, L., et al. Allergy. First published: 23 April 2023
Dupilumab Improves Long-term Outcomes in Patients With Uncontrolled, Moderate-to-Severe GINA-Based Type 2 Asthma, Irrespective of Allergic Status
Rabe, K.F., Pavord, I.D., Busse, W.W., et al. Allergy. First published: 19 April 2023
IgE glycosylation is essential for the function of omalizumab
Plattner, K., Augusto, G.S., Muerner, L., et al. Allergy. First published: 19 April 2023
Temperature regulates Rab3a and mast cell-derived exosomal FcεRI to inhibit mast cell activation
Liao, W., Chen, G., Song, L., et al. Allergy. First published: 17 April 2023
Affinity matters for IgE-blocking activity of allergen-specific antibodies
Strobl, M.R., Demir, H., Stadlmayr, G., et al. Allergy. First published: 15 April 2023
Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma
Papadopoulos, N.G., Szefler, S.J., Bacharier, L.B., et al. Allergy. First published: 14 April 2023
Patient-centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA-EAACI approach
Bousquet, J., Shamji, M.H., Anto, J.M., et al. Allergy. First published: 11 April 2023
Age of onset defines two distinct profiles of atopic dermatitis in adults
Facheris, P., Da Rosa, J.C., Pagan, A.D., et al. Allergy. First published: 09 April 2023
Dupilumab but not cyclosporine treatment shifts the microbiome towards a healthy skin flora in patients with moderate to severe atopic dermatitis
Hartmann, J., Moitinho-Silva, L., Sander, N., et al. Allergy. First published: 09 April 2023
Environmental and Health Hazards by Massive Earthquakes
Bayram, H., Doğan, T.R., Şahin, Ü.A. and Akdis, C.A. Allergy. First published: 07 April 2023
Epithelium-derived cystatin SN inhibits HDM protease activity in allergic asthma
Yao, L., Yuan, X., Fu, H., et al. Allergy. First published: 07 April 2023
In vitro supporting diagnostic tools in plant-food allergy
Antonio, C.J., Clara, L.-M., Reyes, G.-O., et al. Allergy. First published: 06 April 2023
Conditional neutrophil depletion challenges their contribution to mouse models of anaphylaxis
Stackowicz, J., Gillis, C.M., Godon, O., et al. Allergy. First published: 06 April 2023
One in five patients with chronic spontaneous urticaria has IgE to tissue transglutaminase 2
Su, H., Kolkhir, P., Scheffel, J., et al. Allergy. First published: 05 April 2023
Stk4, a key regulator in regulatory T cells homeostasis activity?
Tomei, L. and Céspedes, J.A. Allergy. First published: 05 April 2023
Organ-specific allergen challenges in airway allergy: Current utilities and future directions
Fauquert, JL, Alba-Linero, C, Gherasim, A, et al. Allergy. First published: 01 April 2023
Reply to correspondence “Food allergens to emollients”
Irvine, A.D., Hourihane, J.O.B. and STOP-AD Team. Allergy. First published: 31 March 2023
Correspondence to “Diagnosis of immediate reactions to amoxicillin: Comparison of basophil activation markers CD63 and CD203c in a prospective study”
Elst, J., van der Poorten, M.-L.M., Toscano, A., et al. Allergy. First published: 30 March 2023
Innate lymphoid cells type 2 and CD8+ T cells are perturbed in overweight and obese individuals with asthma
Björkander, S., Maier, P., Kere, M., et al. Allergy. First published: 30 March 2023
Maternal and infant serum carotenoids are associated with infantile atopic dermatitis development
Inoue, Y., Yamamoto, Y., Suzuki, S., et al. Allergy. First published: 30 March 2023
Immunomodulatory properties of mesenchymal stem cells: A potential therapeutic strategy for allergic rhinitis
Wang, M, Zhao, N, Wang, C, Jin, Z-B, Zhang, L. Allergy. First published: 28 March 2023
Risk stratification through extensive allergy work-up in COVID-19-mRNA vaccine allergic reactions
Soria, A., Labella, M., Doña, I., et al. Allergy. First published: 27 March 2023
Adherence and persistence in allergen immunotherapy (APAIT): a reporting checklist for retrospective studies
Pfaar, O., Devillier, P., Schmitt, J., et al. Allergy. First published: 27 March 2023
Resolving the aetiology and treatments of allergic diseases
Zhang, L. and Akdis, C.A. Allergy. First published: 25 March 2023
Is exposure to pollen a risk factor for moderate and severe asthma exacerbations?
Annesi-Maesano, I, Cecchi, L, Biagioni, B, et al. Allergy. First published: 24 March 2023
Anti-CD3 Inhibits Circulatory and Tissue-resident Memory CD4 T Cells that Drive Asthma Exacerbations in Mice
Sethi, G.S., Gracias, D.T., Gupta, R.K., et al. Allergy. First published: 23 March 2023
Disparities and inequalities of penicillin allergy in the Asia-Pacific region
Li, P.H., Pawankar, R., Thong, B.Y.H., et al. Allergy. First published: 23 March 2023
Successful usage of a chatbot to standardize and automate history taking in Hymenoptera venom allergy.
Schneider, S., Gasteiger, C., Wecker, et al. Allergy. First published: 22 March 2023
Atopic dermatitis: correlation of distinct risk factors with age of onset in adulthood compared to childhood
Maintz, L., Schmitz, M.-T., Herrmann, N., et al. Allergy. First published: 22 March 2023
Trait profiles in difficult-to-treat asthma: clinical impact and response to systematic assessment
Lin, T., Jonathan, P., Denton, E., et al. Allergy. First published: 20 March 2023
Dupilumab-associated ocular surface disease in atopic dermatitis patients: clinical characteristics, ophthalmic treatment response, and conjunctival goblet cell analysis
Achten, R., Thijs, J., van der Wal, M., et al. Allergy. First published: 19 March 2023
Legends of Allergy: Gianni Marone
Triggiani, M., Casolaro, V. and Stellato, C. Allergy. First published: 19 March 2023
Global Initiative for Asthma (GINA): 30 years of promoting evidence-based asthma care
Yorgancıoğlu, A., Reddel, H.K. Allergy. First published: 18 March 2023
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
Pfeffer, P.E., Ali, N., Murray, R., et al. Allergy. First published: 17 March 2023
Severe and refractory anaphylaxis in paediatric intensive care unit
Pouessel, G., Trochu, C., Chagnon, F., et al. Allergy. First published: 17 March 2023
Proinflammatory polarization of monocytes by particulate air pollutants is mediated by induction of trained immunity in pediatric asthma
Movassagh, H, Prunicki, M, Kaushik, A, et al. Allergy. First published: 16 March 2023
Prescribing patterns of budesonide/formoterol maintenance and reliever therapy in patients with asthma in Sweden
Janson, C., Melén, E., Licht, S.d.F., et al. Allergy. First published: 15 March 2023
pH sensing shapes immune cell function: The role of GPR65 and its implications for allergic disease
de Souza Ferreira, S., Bek, M.K. and Tibbitt, C.A. Allergy. First published: 14 March 2023
Immune Response Evolution in Peanut Epicutaneous Immunotherapy for Peanut-Allergic Children
Bastin, M., Carr, W.W., Davis, C.M., et al. Allergy. First published: 14 March 2023
PM2.5 chemical constituents and allergic rhinitis: Findings from a prospective cohort study in China
Jia, P., Feng, C., Ye, T., Shao, Y. and Yang, S. Allergy. First published: 11 March 2023
Quantitative analysis of urinary cytokines in food-allergic and healthy individuals
Lee, A.S., Parsons, E.S., Chang, I., et al. Allergy. First published: 11 March 2023
Multiple comparisons and effect size - statistical recommendations for authors planning to submit an article to Allergy
Ordak, M. Allergy. First published: 08 March 2023
An alternative path to oral tolerance
Li, C.H., Kabak, E. and Eiwegger, T. Allergy. First published: 08 March 2023
Acute and Chronic Impacts of Heat Stress on Planetary Health
Sampath, V., Shalakhti, O., Veidis, E., et al. Allergy. First published: 08 March 2023
Dupilumab treatment increases transitional B cells in severe asthma
Lommatzsch, M., Dost, M., Jaishankar, N., et al. Allergy. First published: 08 March 2023
The next generation virus-like particle platform for the treatment of peanut allergy
Sobczak, J.M., Krenger, P.S., Storni, F., et al. Allergy. First published: 08 March 2023
IL-4 drastically decreases deuterosomal and multiciliated cells via alteration in progenitor cell differentiation
Cho, H-J, Chung, YW, Moon, S, et al. Allergy. First published: 08 March 2023
Microglia–neuron interactions promote chronic itch via the NLRP3-IL-1β-GRPR axis
Liu, X, Wang, Y, Zeng, Y, et al. Allergy. First published: 06 March 2023
Determinants of bone density in children with immunoglobulin E-mediated food allergy
Nichols-Vinueza, D.X., Mateja, A., Hatzimemos, A., et al. Allergy. First published: 05 March 2023
IL-21 boosts germinal center response through independent actions on T and B cells in a concentration-dependent manner
Waldetario, M.C.G.M. Allergy. First published: 05 March 2023
Detection of gut and mucosal peptides through TOMAHAQ in healthy individuals
Parsons, E.S., Liu, F., Kaushik, A., et al. Allergy. First published: 05 March 2023
Factors associated with suboptimal response to monoclonal antibodies in severe asthma
Pérez de Llano, L., Marina Malanda, N., Urrutia, I., et al. Allergy. First published: 03 March 2023
In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis
Haasnoot, M.L., Kleuskens, M.T.A., Lopez-Rincon, A., et al. Allergy. First published: 03 March 2023
Citations: 138
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, Aquilina, S, Asero, R, Baker, D, et al. Allergy. 2022; 77: 734– 766
Citations: 98
The role of peripheral blood eosinophil counts in COVID-19 patients
Xie, G, Ding, F, Han, L, Yin, D, Lu, H, Zhang, M. Allergy. 2021; 76: 471– 482
Citations: 70
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
Sokolowska, M., Eiwegger, T., Ollert, M., Torres, M.J., Barber, D., Del Giacco, S., et al. Allergy. 2021; 76: 1629-1639
Citations: 68
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper
Pfaar, O, Klimek, L, Jutel, M, Akdis, C, A, Bousquet, J, Breiteneder, H, et al. Allergy. 2021; 76: 648– 676
Citations: 65
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – An EAACI-ARIA Position Paper
Klimek, L., Jutel, M., Akdis, C.A., Bousquet, J., Akdis, M., Torres, M.J., et al. Allergy. 2021; 76: 1624-1628
Citations: 61
Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1617-1618
Citations: 58
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation
Klimek, L., Novak, N., Cabanillas, B., Jutel, M., Bousquet, J. and Akdis, C.A. Allergy. 2021; 76: 3307-3313
Citations: 55
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M., et al. Allergy. 2021; 76: 1640-1660
Citations: 49
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, Cardona, V, DunnGalvin, A, Garvey, L, H, et al et al. Allergy. 2022; 2022; 77: 357– 377
Citations: 43
The role of allergen-specific IgE, IgG and IgA in allergic disease
Shamji, MH, Valenta, R, Jardetzky, T, Verhasselt, V, Durham, S, R, Würtzen, P, A, et al. Allergy. 2021; 76: 3627– 3641
Citations: 43
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort
Papadopoulos, N.G., Mathioudakis, A.G., Custovic, A., Deschildre, A., Phipatanakul, W., Wong, G., et al. Allergy. 2021; 76: 1765-1775
Citations: 43
Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice
Santos, A.F., Alpan, O. and Hoffmann, H.-J. Allergy. 2021; 76: 2420-2432
Citations: 42
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines
Agache, I., Song, Y., Alonso-Coello, P., Vogel, Y., Rocha, C., Solà, I., et al. Allergy. 2021; 76: 2337-2353
Citations: 39
In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion
Augusto, G, Mohsen, MO, Zinkhan, S, Liu, X, Vogel, M, Bachmann, MF. Allergy. 2022; 77: 111– 117
Citations: 38
Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose!
Krantz, M.S., Bruusgaard-Mouritsen, M.A., Koo, G., Phillips, E.J., Stone, C.A., Jr and Garvey, L.H. Allergy. 2021; 76: 2916-2920
Citations: 37
Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19
Guéant, J.-L., Guéant-Rodriguez, R.-M., Fromonot, J., Oussalah, A., Louis, H., Chery, C., et al. Allergy. 2021; 76: 1846-1858
Citations: 35
Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19
Adamo, S., Chevrier, S., Cervia, C., Zurbuchen, Y., Raeber, M.E., Yang, L., et al. Allergy. 2021; 76: 2866-2881
Citations: 34
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity
Torres, MJ, Trautmann, A, Böhm, I, Scherer, K, Barbaud, A, Bavbek, S, et al. Allergy. 2021; 76: 1325– 1339
Citations: 34
The ingenious mast cell: Contemporary insights into mast cell behavior and function
Dahlin, J.S., Maurer, M., Metcalfe, D.D., Pejler, G., Sagi-Eisenberg, R. and Nilsson, G. Allergy. 2022; 77: 83-99
Citations: 34
Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation
Khaitov, M., Nikonova, A., Shilovskiy, I., Kozhikhova, K., Kofiadi, I., Vishnyakova, L., et al. Allergy. 2021; 76: 2840-2854
Citations: 34
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Citations: 32
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Citations: 31
Skin tests in urticaria/angioedema and flushing to Pfizer-BioNTech SARS-CoV-2 vaccine: Limits of intradermal testing
Bianchi, L., Biondi, F., Hansel, K., Murgia, N., Tramontana, M. and Stingeni, L. Allergy. 2021; 76: 2605-2607
Citations: 31
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
Sokolowska, M, Rovati, GE, Diamant, Z, et al. Allergy. 2021; 76: 114– 130
Citations: 30
Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease
Celebi Sozener, Z, Ozdel Ozturk, B, Cerci, P, et al. Allergy. 2022; 77: 1418– 1449
Citations: 30
Advances and highlights in asthma in 2021
Agache, I, Eguiluz-Gracia, I, Cojanu, C, et al. Allergy. 2021; 76: 3390– 3407
The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2
Hartley, G.E., Edwards, E.S.J., Varese, N., et al. Allergy. First published: 21 December 2022
National trends in the prevalence of allergic diseases among Korean adolescents before and during COVID-19, 2009-2021: A serial analysis of the national representative study
Koo, M.J., Kwon, R., Lee, S.W., et al. Allergy. First published: 28 November 2022
Recent developments in the immunopathology of COVID-19
Zhang, H.-p., Sun, Y.-l., Wang, Y.-f., et al. Allergy. First published: 24 November 2022
Immediate hypersensitivity reactions to anti-SARS-CoV-2 neutralizing monoclonal antibodies: a real-life experience
Franceschini, L. and Farsi, A. Allergy. First published: 16 November 2022
Diagnostic accuracy of vaccine and vaccine excpient testing in the setting of allergic reactions to covid-19 vaccines: a systematic review and meta-analysis
Greenhawt, M., Shaker, M., Golden, D.B.K., et al. Allergy. First published: 02 November 2022
The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients
Ungar, B., Hartzell, S., Lozano-Ojalvo, D., et al. Allergy. First published: 01 October 2022
Implementation of the web-based calculator estimating odds ratio of severe COVID-19 for unvaccinated individuals in a country with high coronavirus-related death toll
Kwasniewski, M., Korotko, U., Chwialkowska, K., et al. Allergy. First published: 21 September 2022
Disproportionate rate of female referrals for suspected COVID-19 vaccine allergies
Chiang, V., Kan, A.K.C., Yim, J.S.H., et al. Allergy. First published: 20 September 2022
Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines
Palomares, F., Paris, J.L., Labella, M., Doña, I., Mayorga, C. and Torres, M.J. Allergy. First published: 01 August 2022
SARS-CoV-2 infection in severe asthma is associated with worsening of COVID-19 through respiratory NLRP3 inflammasome activation
Jeong, J.S., Choi, J.Y., Kim, J.S., et al. Allergy. First published: 24 July 2022
Exposure to avian coronavirus vaccines is associated with increased levels of SARS-CoV-2-cross-reactive antibodies
Ardicli, O, Carli, KT, Satitsuksanoa, P, et al. et al. Allergy. First published: 23 July 2022
Urticaria and/or angioedema secondary to mRNA COVID-19 vaccines: Updates from a United States case registry
Anvari, S., Samarakoon, U., Fu, X., et al. Allergy. First published: 16 July 2022
The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma
Kim, J.G., Zhang, A., Rauseo, A.M., et al. Allergy. First published: 15 July 2022
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity
Worm, M., Alexiou, A., Bauer, A., et al. Allergy. First published: 20 June 2022
Presentation of airway and general symptoms in COVID-19 caused by dominant SARS-CoV-2 variants: a follow-up on ARIA consensus
et al. Allergy. First published: 14 June 2022
Immune-inflammatory proteome of elite ice hockey players before and after SARS-CoV-2 infection
Maurer, D.J., Barletta, E., Heider, A., et al. Allergy. First published: 12 June 2022
Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post–infection and post-vaccination cellular SARS-CoV-2-specific immune response
Kratzer, B., Schlax, L.C., Gattinger, P., et al. Allergy. First published: 12 June 2022
T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19
Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022
Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses
Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 14 May 2022
COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab
Francis, C.H.R., Hearn, A.P., Ratnakumar, S., et al. Allergy. First published: 01 May 2022
Effect of BTN162b2 and Coronavac boosters on humoral and cellular immunity of individuals previously fully vaccinated with Coronavac against SARS-CoV-2: A longitudinal study
Kuloğlu, Z.E., El, R., Guney-Esken, et al. Allergy. First published: 19 April 2022
Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern
Rothen, D.A., Krenger, P.S., Nonic, A., et al. Allergy. First published: 11 April 2022
Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures
Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022
Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants
Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022
Are health care policies for COVID-19 evidence-based?
Bonini, S. and Fiorito, S. Allergy. First published: 30 March 2022
Virus-related stimuli modulate SARS-CoV-2 entry factor expression in pediatric tonsillar epithelial cells in vitro
Hara, M., Morimoto, N., Watabe, T., et al. Allergy. First published: 29 March 2022
Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?
Eberlein, B., Sonja, M., Fischer, J., Darsow, U., Biedermann, T. and Brockow, K. Allergy. First published: 10 March 2022
Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization
Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022
February 2023 - Food Allergy and Allergic/Inflammatory Gastrointestinal Diseases
Volume 78 | Issue 2
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, et al. Allergy. 2022; 77: 734– 766
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Advances and recent developments in asthma in 2020
Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146
The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update
Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Open Access Agreements with Wiley
Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
17th World Immune Regulation Meeting
As ever, immune regulation is the hottest issue in basic and clinical sciences. With an outstanding list of speakers in this field, WIRM will be one of the key scientific event of the year 2023, being big enough to learn from other disciplines and small enough to personally meet the experts. Check out the website for more information by clicking here.
Junior Members Corner
Dear Junior Members,
On Monday, 3 April, board members of the Junior Member Assembly (JMA) had the great opportunity to visit the Allergy Journal offices, and the Swiss Institute of Allergy and Asthma Research (SIAF) in Davos, Switzerland.
In the morning, the Junior Members met with Prof. Cezmi Akdis, Editor-in-Chief of the Allergy Journal, and the Allergy Editorial Team (Laura Alberch, Managing Editor; Anna Globinska, Graphics Editor; Rüya Kilic Ögülür, Online Media Editor) to discuss state of the art and future perspectives regarding the fruitful collaboration between Allergy journal and JMA. Collaborations on numerous ambitious projects have been discussed, specifically focusing on educational programs.
After the meeting, the JM were guided through the SIAF Labs and facilities, and they met SIAF Principal Investigators and research teams.
After the lunch with an amazing mountain and lake view, JM and SIAF researchers joined together for an informative and pleasant symposium, where they discussed cutting-edge scientific ideas:
- Mattia Giovannini: Anaphylaxis Phenotypes in Children
- Cristina Boccabella: Small Airways Disease (SAD) in severe asthma as a novel endpoint and distinct target for Mepolizumab (SASAM Study)
- Riccardo Castagnoli: Translational approaches to dissect microbiota-host interactions in inborn errors of immunity
- Rubén Fernández-Santamaría: Cellular recognition of drug antigenic determinants. New parameters to improve in vitro tests.
- Yasutaka Mitamura: Diving deep into skin immunology: Novel subsets of macrophages, dendritic cells, T cells and fibroblasts and their interactions in atopic dermatitis
- Urszula Radzikowska: Immune metabolism
- Ismail Ogülür: Food emulsifiers, dishwasher detergents and epithelitis
- Duygu Yazici: Organochips (organ-on-a-chips) and future of the epithelial barrier research
- Damir Zhakparov: Feature Selection Workflow for RNAseq Datasets with regard to Biomedical Relevance
- Yagiz Pat: Organoids and future of epithelial barrier research
- Manal Bel Imam: B cells, antibodies and biomarkers in eosinophilic esophagitis.
- Pattraporn Satitsuksanoa: Distinct mechanisms of induced and natural immune tolerance
For the Junior Members, it has been an unforgettable experience!
We encourage all the JM to attend the World Immune Regulation Meeting (WIRM) 2023 that will be held in Davos from 5 to 8 July 2023 (more info available at https://www.wirm.ch/).It will be a wonderful opportunity to meet all the SIAF researchers and other international experts in the beautiful city of Davos.
Best regards,
The Junior Member Assembly
EAACI Patients Organisation Committee Corner
The EAACI Patients Organisation Committee (POC) aims to be the patients reference body in the field of Allergology, representing patients of all nationalities across the globe, and promoting patient-centred healthcare in the specialty. The POC is currently comprised of 33 members which are patient support organizations working at the local, national, regional and international levels. The committee aims to build cross-sector alliances and working collaboratively with EAACI members, policy makers, and industry representatives. Activities undertaken by the POC include:
The POC meets 4 to 6 times per year virtually and pre-covid, would meet in person at one EAACI conference per year and focused meetings such as FAAM and PAAM. These sessions provide the forum to discuss common issues, align on actions and share best practices. Most recently, they have provided a good platform to discuss international efforts at CODEX and engage in global research priorities.
EAACI POC is truly international in its focus with representation from 30 countries listed at this link. With this representation, it is well positioned to work with EAACI in support of patient needs on a global scale.
- Providing EAACI with the patient and carer real life experience of living with allergic diseases and asthma
- Engaging and contributing patient perspectives through participation in EAACI Sections, Conferences, Interest Groups, Working Groups, Committees, and Task Forces
- Building cross-sector alliances and promoting collaboration between patient group members and other EAACI members, policy makers, and industry representatives with specific focus on priorities that are common across geographies
- Bringing patient organisations from around the world to discuss, align and promote patient-organisation led education, advocacy and research initiatives
- Building broad based awareness of the burden of allergic diseases and asthma
The POC meets 4 to 6 times per year virtually and pre-covid, would meet in person at one EAACI conference per year and focused meetings such as FAAM and PAAM. These sessions provide the forum to discuss common issues, align on actions and share best practices. Most recently, they have provided a good platform to discuss international efforts at CODEX and engage in global research priorities.
EAACI POC is truly international in its focus with representation from 30 countries listed at this link. With this representation, it is well positioned to work with EAACI in support of patient needs on a global scale.
Photo from FAAM 2018
Photo credit: Yanne Boloh
